Residual Tumor Burden After Immunotherapy Predicts Survival in Esophageal Cancer
A real-world study of 178 esophageal cancer patients shows that residual tumor grade and post-treatment lymph node status, especially ypN3, ...
A real-world study of 178 esophageal cancer patients shows that residual tumor grade and post-treatment lymph node status, especially ypN3, ...
A Dutch longitudinal study of nearly 1,900 patients identified three stable gastrointestinal symptom severity profiles during the first year after ...
A multicenter study finds that skeletal muscle measured on routine staging CT scans predicts treatment tolerance, surgical complications and survival ...
A new review finds that bacterial overgrowth is frequently flagged after gastrointestinal cancer surgery, but altered gut anatomy makes breath ...
A phase II trial found that adjuvant sintilimab monotherapy after surgery met its primary efficacy endpoint with 87.5 percent one-year ...
A sweeping 2024–2025 evidence review shows immune checkpoint inhibitors, frailty-adapted surgery, and artificial intelligence converging to transform esophageal cancer treatment ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine